Insider Transactions Reported by 12 Insiders of SUPERNUS PHARMACEUTICALS, INC.

Symbol
SUPN on Nasdaq
Location
Rockville, MD

Insiders trading volume in the past year

SUPERNUS PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jack A. Khattar President, CEO, Director $110,148,127 -$18,546,714 -14% 18 Feb 2026
Tami Tillotson Martin Sr. V.P., Regulatory Affairs $2,631,048 23 Feb 2024
JOHN M. SIEBERT Director $2,555,624 23 Feb 2024
CHARLES W. NEWHALL III Director $1,730,637 -$1,539,270 -47% 18 Feb 2026
Carrolee Barlow Director $1,073,687 18 Feb 2026
Frederick M. Hudson Director $973,422 -$315,133 -24% 18 Feb 2026
Frank Mottola SVP, Chief Tech. Ops. Officer $930,958 -$1,860,640 -67% 18 Feb 2026
GEORGES GEMAYEL Director $919,413 18 Feb 2026
Padmanabh P. Bhatt Sr. VP of IP, CSO $742,610 -$31,552 -4.1% 18 Feb 2026
Jonathan Rubin SVP, Chief Medical Officer $606,878 -$36,292 -5.6% 18 Feb 2026
Timothy C. Dec Senior Vice-President & CFO $253,934 -$524,092 -67% 18 Feb 2026
Bethany Sensenig Director $177,658 -$226,840 -56% 18 Feb 2026

Recent Insider Transactions by Companies or Individuals for SUPERNUS PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.